首页 | 本学科首页   官方微博 | 高级检索  
检索        

锶-89联合热疗治疗骨转移癌的疗效观察
引用本文:张磊,刘啸,王艳军,张学勇.锶-89联合热疗治疗骨转移癌的疗效观察[J].中国辐射卫生,2016,25(5):622-624.
作者姓名:张磊  刘啸  王艳军  张学勇
作者单位:山东聊城第二人民医院血液肿瘤科, 山东临清 252600
摘    要:目的 探讨锶-89联合热疗治疗骨转移癌的疗效。方法 将70例患者随机分为两组,实验组(35例)接受锶-89联合热疗治疗,对照组(35例)接受锶-89治疗,观察治疗2周后两组的镇痛疗效及体力情况。结果 治疗2周后实验组的癌痛缓解率为82.8%,对照组为60%,两组比较差异有统计学意义(P < 0.05)。实验组和对照组KPS改善率分别为57.1%和31.4%,差异有统计学意义(P < 0.05)。结论 锶-89联合热疗可以控制骨转移癌引起的疼痛;锶-89联合热疗可作为临床治疗骨痛的一种较理想的选择。

关 键 词:骨转移癌  锶-89  热疗  疗效  
收稿时间:2016-05-17

Clinical Observation of 89Sr Radio-Therapy Combined with Hyperthermia for Pain on Bone Metastasis
ZHANG Lei,LIU Xiao,WANG Yan-jun,ZHANG Xue-yong.Clinical Observation of 89Sr Radio-Therapy Combined with Hyperthermia for Pain on Bone Metastasis[J].Chinese Journal of Radiological Health,2016,25(5):622-624.
Authors:ZHANG Lei  LIU Xiao  WANG Yan-jun  ZHANG Xue-yong
Institution:Department of Hematology and Oncology, the Second People's Hospital of Liaocheng LinQing 252600, ShanDong
Abstract:Objective To study the efficacy observation of bone metastases treated by 89Sr radio-therapy combined with hyperthermia. Methods A total of 70 patients were randomly divided into two groups. The experiment group(n=35) received 89Sr radio-therapy combined with hyperthermia and the control group(n=35) received only 89Sr radio-therapy. The efficacy and physical situation were observed two weeks after treatment. Results The experimental pain relief rate was 82.8%, the control group was 60%, comparing the two groups was statistically significant difference (P < 0.05). The experimental group and control group KPS improvement rate were 57.1% and 31.4%,the difference was statistically significant (P < 0.05). Conclusion 89Sr radio-therapy combined with hyperthermia can control the pain on bone metastasis which serves as a better therapeutic choice for pain on bone metastasis.
Keywords:Bone Metastasis  89Sr Radio-Therapy  Hyperthermia  Efficacy  
本文献已被 CNKI 等数据库收录!
点击此处可从《中国辐射卫生》浏览原始摘要信息
点击此处可从《中国辐射卫生》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号